Ha-Jong Lee

Ha-Jong Lee Email and Phone Number

RA Director, New Drug Development Division @ Dx & Vx
Ha-Jong Lee's Location
Seoul, South Korea, Korea, Republic of
Ha-Jong Lee's Contact Details

Ha-Jong Lee work email

Ha-Jong Lee personal email

n/a
About Ha-Jong Lee

Ha-Jong Lee is a RA Director, New Drug Development Division at Dx & Vx. She possess expertise in regulatory affairs, pharmaceutical industry, lifesciences, biopharmaceuticals, clinical trials and 19 more skills. She is proficient in 영어 and 한국어.

Ha-Jong Lee's Current Company Details
Dx & Vx

Dx & Vx

View
RA Director, New Drug Development Division
Ha-Jong Lee Work Experience Details
  • Dx & Vx
    Director
    Dx & Vx Jul 2023 - Present
    대한민국 서울
    - Develop submission strategies and plan study regulatory timeline- Management of FDA , EMA, MFDS and NMPA submission regards on going project- Management of FDA, EMA, MFDS and NMPA submission timeline- Assess regulatory aspe cts of study feasibility, support development team- Develop regulatory strategies and implementation plans in responsible territories for the preparation and submission of company pipelines and aligned with company goal- Manage Medicine, Vaccine, Medical dev ice, IVD and Health functional food regulatory process- Communicate with authorities/vendors/partner companies- Train and Manage of juniors
  • Canariabio Group
    Head Of Ra
    Canariabio Group Jan 2023 - Jul 2023
    대한민국 서울
    - Develop submission strategies and plan study regulatory timeline- Management of FDA submission regards on going project- Management of FDA submission timeline- Manage FDA IND (Form 1571) amendments (10 IND amendments were completed)- Successfully submitted and obtained ODD (Orphan Drug Designation) for B revaRex Pancreatic Cancer- Successfully submitted DSUR (Development Safety Update Report) for OvaRex Ovarian Cancer- Management of vendors- Manage authority’s regulations- Communicate with authorities/vendors/partner companies- Train and Manage of juniors
  • Nexturn Bio
    Director
    Nexturn Bio May 2021 - Dec 2022
    강남구, 서울특별시, 대한민국
    - Develop submission strategies and plan study regulatory timeline- Communicate with MFDS regards projects, queries, etc.- Manage global partner (RosVivo) regards Non-clinical and Pre-IND implementation- Discuss and implement strategies on miRNA regards Pre-IND submission- Search how to implement non-clinical studies in US and Korea- Participated INTERBIZ 2 times (2021 & 2022)- Manage FDA submission for non-clinical and Pre-IND submission- Communicate/manage venture capital company/investment company- Review venture capital company / investment company- Provide and manage juniors regards regulatory pathway / guideline- Support medical device department to submit class 2-3 medical devices to MFDS- Support medical device department on national assignments- Give guidance how to submit medical device to MFDS- Give guidance how to submit IND / NDA / BLA to MFDS and FDA- Review recent guideline from MFDS to provide regulatory intelligence/pathway to relevant team/person- Review guideline from FDA to provide regulatory intelligence/pathway to client, global partner and relevant team/person- Plan and review company’s upcoming strategies and goals- Review projects evaluation
  • Psi Cro Korea
    Senior Regulatory Officer
    Psi Cro Korea Sep 2020 - Apr 2021
    대한민국 서울
    - Develop submission strategies and plan study regulatory timeline- Track changes/amendments to legislation requirements related to clinical research and maintain the database of regulatory requirements- Assess regulatory aspects of study feasibility, support development team- Prepare clinical trial submission dossiers for MFDS - Submitted 9 INDs (Phase I, II and III) and received approvals for all of INDs- Communicate with regulatory authorities (MFDS), project teams and vendors on regulatory-related matters- Review translations of essential documents subject to submission- Track regulatory project documentation flow- Manage safety reporting to authorities- Deliver regulatory training to project team
  • Sillajen
    Senior Manager
    Sillajen Aug 2019 - Sep 2020
    영등포구, 서울특별시, 대한민국
    - Review all regulatory agency submission materials to ensure timeliness, accuracy, comprehensiveness, or compliance with regulatory standards.- Provide responses to regulatory agencies regarding product information or issues.- Develop regulatory strategies and implementation plans in responsible territories for the preparation and submission of new products, aligned with company goal.- In responsible territories, preparation and submission of regulatory agency applications, reports, or correspondence.- Manage MFDS submission for IND follow-up (amendment), IB amendment, Protocol amendment and CSR submission- Participate in the development or implementation of clinical trial protocols.- Maintain current knowledge of relevant regulations, ICH-GCP and company SOPs including proposed and final rules.- Train and assist the clinical staff in improving compliance with applicable regulatory requirements and guidelines- Communicate with MFDS and FDA agencies- Manage global partner companies
  • 유틸렉스 (Eutilex)
    Senior Research Scientist
    유틸렉스 (Eutilex) Aug 2018 - Aug 2019
    대한민국 서울
    - Gather information / documentation from relevant departments to prepare FDA submission- Communicate/bridging role between Eutilex and global partner (CRO)- Prepare core documents for eCTD submission- Prepare and gather regulatory perspective information for FDA- Provide relevant information and/or core document to discuss current project to collaborate with partners- Communicate with global CRO to set up project timeline and managing projects
  • Merck Life Science
    Regulatory Expert (Rm Head Leader)
    Merck Life Science Oct 2016 - Aug 2018
    Seoul
     Managing Products under Korea Regulation with compliance ways (Different Categories) Biologics- Closely work with Authority to discuss import process in compliance way- Work on LMO/GMO to be declared prior to import into Korea (Import declaration)- Reviewed more than 8,000 biologic (animal derived product, antibody, etc.) products to verify CoO (Country of Origin) and import requirement to safely imported into Korea- Have occasion meeting with authority to discuss format of import declaration as well as VC (Health Certificate)- Successfully negotiate with authority to accept propose to change format of health certificate with relevant thesis based on Korea regulation- Frequent communication with QIA (Quarantine Inspection Agency) to discuss most up dated guideline to eliminate obstacles in advance Electricity & Radio Wave (Equipment)- Analyzing E&E equipment (total 729 products) and clarify which products falls under KATS (Korean Agency Technology and Standard) and/or RRA (National Radio Research Agency)- Collaborate with Designated Test Institute to receive Certification or Exemption- Discuss with Business departments to prioritize products which need to receive certification for importation- Communicate with Global to discuss necessary require documents for E&E products to be certified in Korea Pharma/Food Materials- Collaborate with Pharma department to verify which products can be imported into Korea without hurdle under Korea regulation- Conduct labels for pharmaceutical raw material products- Review food material (Flavor and Fragrance) which can be imported into Korea or not- Conduct labels for food material products  MD/IVD- Review MD/IVD products whether it can be imported into Korea- Conduct labels for MD/IVD HS Code project- Collaborate with marketing team to prioritize products in compliance way of HS Code- Approximately 80,000 products classified by 4 priorities
  • Celltrion
    Project & Country Manager
    Celltrion Apr 2011 - Aug 2016
    - Project Manager for CT-P10 3.4 LTBFL (Managing 26 countries and 151 sites) project- Act as Regional Manager who maintain clinical trial will be ended within specific timeline- Managing clinical trials for specific projects (communicate with doctors) - Bridging Role between CRO (PPD) regards site pending issues as well as communicate with KOL (Key Opinion Leaders)- Acquired NOC (Notice of Compliance) from Health Canada. - Country Manager in Canada and Balkan region (6 countries including Serbia, Bosnia, Macedonia, Montenegro, Albania and Kosovo) who gathers regulatory intelligence and implement regulatory activities- Regulatory Activity has been conducted and still working throughout responsible countries- eCTD Submission to major pharmaceutical countries (EMA, Canada) as Project Manager- Manage eCTD Generation and eCTD Submission to EMA (3 times – as additional submission, sequence 0006 ~ 0008) as well as respond DL (Deficiency Letter) and Health Canada (25times – Implemented from Original submission to present submission) as well as respond Clarifax (similar to DL)- eCTD Expert (in Word and PDF as well as XML file) who collaborated with one of the most well-known company (CSC)- Dossier Filing (Canada, Australia, New Zealand, Serbia and Bosnia) for monoclonal antibody (mAb) Biosimilar products- ROW Dossier Building (Canada, Australia, New Zealand, Serbia and Bosnia), based on ICH CTD submitted to EMA and also redacted dossier building - eCTD In-house Project Vendor Selection (CSC)and Implementation in terms of software transit and internal personnel training in order to generate eCTD documents for dossier submission- CTD / eCTD Generation and Formatting in terms of generates bookmark, hyperlinks (internal / external) in MS word and PDF as well
  • Hanmi Pharmaceuticals
    Product Manager
    Hanmi Pharmaceuticals Jun 2010 - Dec 2010
    - Introduced various medical device products to hospital staffs- Conducted workshops as a subject matter expert for hospital staffs- Relentlessly marketed Hanmi Medicare products to various hospitals and clinics
  • Republic Of Korea Army
    Sergeant
    Republic Of Korea Army May 2008 - Mar 2010
    - Led 15 subordinate soldiers during training missions and war games- Responsible for morale, physical and mental well beings of junior soldiers- Successfully fulfilled compulsory national service according to South Korea’s constitution

Ha-Jong Lee Skills

Regulatory Affairs Pharmaceutical Industry Lifesciences Biopharmaceuticals Clinical Trials Pharmaceutics Medical Devices Fda Sop Gmp Ectd Ctd Epidemiology Biologics Biosimilars Health Canada Balkans Module 1 Module 2 Module 3 Module 5 Clinical Study Design English Korean

Ha-Jong Lee Education Details

Frequently Asked Questions about Ha-Jong Lee

What company does Ha-Jong Lee work for?

Ha-Jong Lee works for Dx & Vx

What is Ha-Jong Lee's role at the current company?

Ha-Jong Lee's current role is RA Director, New Drug Development Division.

What is Ha-Jong Lee's email address?

Ha-Jong Lee's email address is ha****@****ion.com

What schools did Ha-Jong Lee attend?

Ha-Jong Lee attended Northern Illinois University, Indiana Wesleyan University.

What are some of Ha-Jong Lee's interests?

Ha-Jong Lee has interest in Social Services, Education, Environment, Disaster And Humanitarian Relief, Animal Welfare, Health.

What skills is Ha-Jong Lee known for?

Ha-Jong Lee has skills like Regulatory Affairs, Pharmaceutical Industry, Lifesciences, Biopharmaceuticals, Clinical Trials, Pharmaceutics, Medical Devices, Fda, Sop, Gmp, Ectd, Ctd.

Not the Ha-Jong Lee you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.